A high-throughput screening assay for dipeptidyl peptidase-IV inhibitors using human plasma-Reference-Cited by-同舟云学术

A high-throughput screening assay for dipeptidyl peptidase-IV inhibitors using human plasma

Published:2021 Issue:24 Volume:13 Page:2671-2678
ISSN:1759-9660
Container-title:Analytical Methods
language:en
Short-container-title:Anal. Methods

Author:

Zhang Jing¹²³⁴,Qian Xing-Kai¹²³⁴^ORCID,Song Pei-Fang¹²³⁴,Li Xiao-Dong¹²³⁴,Wang An-Qi¹²³⁴,Huo Hong⁵⁴,Yao Jing-Chun⁶⁷⁸⁴,Zhang Gui-Min⁶⁷⁸⁴,Zou Li-Wei¹²³⁴^ORCID

Affiliation:

1. Institute of Interdisciplinary Integrative Medicine Research

2. Shanghai University of Traditional Chinese Medicine

3. Shanghai

4. China

5. Dalian Institute of Chemical Physics

6. State Key Laboratory of Generic Manufacture Technology of Traditional Chinese Medicine

7. Lunan Pharmaceutical Group Co. Ltd

8. Linyi

Abstract

A high-throughput screening assay for dipeptidyl peptidase-IV inhibitors.

Funder

Shanghai University of Traditional Chinese Medicine

National Key Research and Development Program of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Chemical Engineering,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/AY/D1AY00415H

Reference54 articles.

1. Epidemiological Perspectives of Diabetes

2. Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis

3. Phytopharmacological Strategies in the Management of Type 2 Diabetes Mellitus

4. International Diabetes Federation , IDF Diabetes Atlas , http://www.diabetesatlas.org

5. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visualizing Dipeptidyl Peptidase-IV with an Advanced Non-π-Conjugated Fluorescent Probe for Early Thyroid Disease Diagnosis;Analytical Chemistry;2023-11-21

2. An optimized NIR fluorescent probe for visualizing DPP IV and applications in the diagnosis and therapy of inflammatory bowel diseases;Sensors and Actuators B: Chemical;2023-11

3. Cell-Penetrating Milk-Derived Peptides with a Non-Inflammatory Profile;Molecules;2023-10-09

4. Discovery of anthraquinones as DPP-IV inhibitors: Structure-activity relationships and inhibitory mechanism;Fitoterapia;2023-07

5. Licochalcone A Derivatives as Selective Dipeptidyl Peptidase 4 Inhibitors with Anti-Inflammatory Effects;Journal of Natural Products;2023-06-20